ACM
ACAD icon

ADAR1 Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

ADAR1 Capital Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$986K Buy
+38,955
New +$857K 0.05% 171
2024
Q4 		– Sell
-23,100
Closed -$355K – 216
2024
Q3 		$355K Buy
23,100
+21,800
+1,677% +$364K 0.06% 133
2024
Q2 		$21.1K Buy
1,300
+800
+160% +$12.9K ﹤0.01% 217
2024
Q1 		$9.24K Buy
+500
New +$12.4K ﹤0.01% 229

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

ADAR1 Capital Management's ACAD Position: Q2 2026 in Review

ADAR1 Capital Management opened a new position in Acadia Pharmaceuticals (ACAD) in Q2 2026: 38,955 shares worth $986K. The stake represents 0.05% of the portfolio and ranks #171 among its holdings. This is a return to the name: ADAR1 Capital Management previously reported a position in ACAD as recently as Q3 2024.

ADAR1 Capital Management first reported a position in ACAD in Q1 2024 and has held it in 4 quarters since. 354 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • ADAR1 Capital Management held 38,955 shares of Acadia Pharmaceuticals worth $986K as of Q2 2026.
  • Acadia Pharmaceuticals was a new ADAR1 Capital Management position in Q2 2026.
  • Acadia Pharmaceuticals made up 0.05% of ADAR1 Capital Management's portfolio in Q2 2026, its #171 holding.
  • ADAR1 Capital Management first reported a position in Acadia Pharmaceuticals in Q1 2024 and has held it in 4 quarters since.
  • 354 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.